7-132130584-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_020911.2(PLXNA4):c.5590-10C>T variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.751 in 1,613,362 control chromosomes in the GnomAD database, including 458,905 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.70 ( 38019 hom., cov: 32)
Exomes 𝑓: 0.76 ( 420886 hom. )
Consequence
PLXNA4
NM_020911.2 splice_polypyrimidine_tract, intron
NM_020911.2 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.00008983
2
Clinical Significance
Conservation
PhyloP100: 0.512
Genes affected
PLXNA4 (HGNC:9102): (plexin A4) Predicted to enable semaphorin receptor activity. Predicted to be involved in several processes, including axon guidance; positive regulation of axonogenesis; and regulation of GTPase activity. Predicted to act upstream of or within several processes, including nervous system development; regulation of axon extension involved in axon guidance; and regulation of negative chemotaxis. Predicted to be located in plasma membrane. Predicted to be part of semaphorin receptor complex. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 7-132130584-G-A is Benign according to our data. Variant chr7-132130584-G-A is described in ClinVar as [Benign]. Clinvar id is 3060928.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.807 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLXNA4 | NM_020911.2 | c.5590-10C>T | splice_polypyrimidine_tract_variant, intron_variant | ENST00000321063.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLXNA4 | ENST00000321063.9 | c.5590-10C>T | splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_020911.2 | P1 | |||
PLXNA4 | ENST00000359827.7 | c.5590-10C>T | splice_polypyrimidine_tract_variant, intron_variant | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.697 AC: 105929AN: 151944Hom.: 38001 Cov.: 32
GnomAD3 genomes
AF:
AC:
105929
AN:
151944
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.737 AC: 183123AN: 248586Hom.: 68480 AF XY: 0.740 AC XY: 99826AN XY: 134898
GnomAD3 exomes
AF:
AC:
183123
AN:
248586
Hom.:
AF XY:
AC XY:
99826
AN XY:
134898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.757 AC: 1105717AN: 1461300Hom.: 420886 Cov.: 55 AF XY: 0.755 AC XY: 548620AN XY: 726966
GnomAD4 exome
AF:
AC:
1105717
AN:
1461300
Hom.:
Cov.:
55
AF XY:
AC XY:
548620
AN XY:
726966
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.697 AC: 105999AN: 152062Hom.: 38019 Cov.: 32 AF XY: 0.701 AC XY: 52095AN XY: 74334
GnomAD4 genome
AF:
AC:
105999
AN:
152062
Hom.:
Cov.:
32
AF XY:
AC XY:
52095
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2419
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PLXNA4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at